Plexin-B2 Negatively Regulates Macrophage Motility, Rac, and Cdc42 Activation by Roney, Kelly E. et al.
Plexin-B2 Negatively Regulates Macrophage Motility,
Rac, and Cdc42 Activation
Kelly E. Roney
1,2, Brian P. O’Connor
3, Haitao Wen
1,2, Eda K. Holl
1,2, Elizabeth H. Guthrie
2, Beckley K.
Davis
1, Stephen W. Jones
2,4, Sushmita Jha
2, Lisa Sharek
4, Rafael Garcia-Mata
4, James E. Bear
2,3, Jenny
P.-Y. Ting
1,2*
1Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, 2Lineberger
Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, 3Integrated Department of Immunology,
Center for Genes, Environment and Health, National Jewish Health, Denver, Colorado, United States of America, 4Department of Cell and Developmental Biology,
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America
Abstract
Plexins are cell surface receptors widely studied in the nervous system, where they mediate migration and morphogenesis
though the Rho family of small GTPases. More recently, plexins have been implicated in immune processes including cell-
cell interaction, immune activation, migration, and cytokine production. Plexin-B2 facilitates ligand induced cell guidance
and migration in the nervous system, and induces cytoskeletal changes in overexpression assays through RhoGTPase. The
function of Plexin-B2 in the immune system is unknown. This report shows that Plexin-B2 is highly expressed on cells of the
innate immune system in the mouse, including macrophages, conventional dendritic cells, and plasmacytoid dendritic cells.
However, Plexin-B2 does not appear to regulate the production of proinflammatory cytokines, phagocytosis of a variety of
targets, or directional migration towards chemoattractants or extracellular matrix in mouse macrophages. Instead, Plxnb2
2/2
macrophages have greater cellular motility than wild type in the unstimulated state that is accompanied by more active,
GTP-bound Rac and Cdc42. Additionally, Plxnb2
2/2 macrophages demonstrate faster in vitro wound closure activity. Studies
have shown that a closely related family member, Plexin-B1, binds to active Rac and sequesters it from downstream signaling.
TheinteractionofPlexin-B2with Rachasonlybeenpreviouslyconfirmedinyeastandbacterialoverexpressionassays.Thedata
presented here show that Plexin-B2 functions in mouse macrophages as a negative regulator of the GTPases Rac and Cdc42
and as a negative regulator of basal cell motility and wound healing.
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Introduction
The plexins are a family of nine transmembrane proteins that are
grouped by homology into four subfamilies: A, B, C, and D [1]. All
family members share an extracellular semaphorin domain and an
intracellular plexin domain-containing tail that can mediate
intracellular signaling. The plexins were originally identified in
the nervous system [2,3], where they have been found to mediate
diverse cell processes including axon guidance, neurogenesis, cell
migration, cell proliferation and death.Plexins have also been found
to function in other body systems including the reproductive,
circulatory, endocrine, urinary, digestive, and immune system
[reviewed in 4,5,6]. Similar to other plexins, the B family of plexins
were originally found in the nervous system [1], and were later
identified in the circulatory, endocrine, reproductive, urinary,
digestive, respiratory, and immune systems [7–15]. The B plexin
family is distinct from the A, C, and D plexins in the domains found
in the intracellular tail. Two of the B family members, Plexin-B1
and Plexin-B2, contain an intracellular domain with a PDZ motif
[post synaptic density protein (PSD95), Drosophila disc large tumor
suppressor (DlgA), and zonula occludens-1 protein (zo-1)], which
can relay extracellular signals to intracellular motifs [16–21].
In contrast to a paucity of studies on Plexin-B2, Plexin-B1 has
been found in the immune system where it mediates processes
similar to its function in the nervous system. Plexin-B1 is required
for the optimal migration of monocytes and dendritic cells and
proliferation and survival of B cells [22,23]. The mechanisms
mediating these effects of Plexin-B1 in the immune system are
unknown, but in other cell types the phenotypic effects of Plexin-
B1 have been attributed to its role as a regulator of the Rho family
of GTPases [18,19,21,24–26]. The Rho family of GTPases
functions to regulate actin dynamics [27,28]. Plexin-B1 has been
shown to regulate Rho upon stimulation by binding to PDZ-Rho
and LARGE [18,19,21,24]. Plexin-B1, as well as Drosophila
Plexin-B, have been shown to bind directly to the active GTP-
bound form of the GTPase Rac but not the inactive, GDP bound
form [24,29,30]. The downstream consequences of B family
plexins binding to active Rac are not completely understood. In
overexpression studies performed in HEK293 cells, Plexin-B1-
Rac-GTP binding has been shown to sequester active Rac from its
downstream effector p-21-activated kinase (PAK), which leads to
increased cell surface expression of Plexin-B1 [30]. In Drosophila
neurons, which have only one B family plexin, Plexin B binds to
and down regulates Rac through an unknown mechanism [29].
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24795Plexin-B2, the focus of our work, has been studied much less
than Plexin-B1. In overexpression studies Plexin-B2 has been
found to regulate the GTPase Rho [16]. When Plexin-B2 is
synthetically stimulated by replacement of its extracellular domain,
the intracellular PDZ domain of Plexin-B2 binds to the PDZ
domain of the RhoGEFs (guanine nucleotide exchange factors)
PDZ-RhoGEF and LARGE (leukemia associated RhoGEF),
leading to the activation of Rho and the formation of stress fibers
in fibroblast [16]. Studies of Plexin-B2 in the mouse nervous
system have demonstrated that Plexin-B2 is required for normal
development during embryogenesis. Plxnb2
2/2 embryo brains
have defects in cortical patterning and in cell guidance of several
cell types, resulting in neural tube closure defects and exencephaly
[31,32]. In the immune system, the function of Plexin-B2 has not
been delineated, although Plexin-B2 has been identified on B cells
as a marker of T dependent germinal center formation and on an
undefined population of CD11b
+ cells in the mouse liver [7,33].
The function of Plexin-B2 on these cells types has not been
reported.
We examined the expression and function of Plexin-B2 in the
immune system and observed high Plexin-B2 expression in
macrophages, conventional dendritic cells (cDC), and plasmacy-
toid dendritic cells (pDCs). To explore the effects Plexin-B2 on the
immune system, we created fetal liver chimeric mice to
reconstitute the immune system of wild type mice with Plxnb2
2/2
cells because the Plxnb2
2/2 mice do not survive post-partum.
Reconstitution of the immune system with Plxnb2
2/2 cells has
similar efficiency as reconstitution with wild type cells providing a
feasible system for this study. The results show that Plxnb2
2/2
macrophages are not defective in their ability to secrete the
inflammatory cytokines TNF or IL-6, or phagocytose fluorescent
beads, Escherichia coli (E. coli), or antibody bound T cells. Plxnb2
2/2
macrophages are also not defective in the ability to migrate towards
the recruiting cytokines stromal cell-derived factor-1 (CXCL12),
macrophage colony stimulating factor (M-CSF), serum, or the
extracellular matrix protein fibronectin. However, Plxnb2
2/2
macrophages show a significant increase in cell motility in the
steady state and are capable of in vitro wound closure at a faster rate
compared to wild type. Additionally Plxnb2
2/2 cells have higher
levels of the active forms of the small Rho GTPases Cdc42 and Rac
at the basal rate. These data show that Plexin-B2 is a negative
regulator of Rac and Cdc42 and modulates cell motility in
macrophages.
Results
Plexin-B2 is expressed in the immune system
We and others have previously shown that Plexin-A1 is found
on dendritic cells in the mouse immune system and is required
for optimal stimulation of T cells and for proper formation of T
cell-dendritic cell conjugates by influencing actin polarization
[5,34–36]. These results prompted us to ask if other plexins were
expressed in the immune system. In silico analysis of the BioGPS
database [37] demonstrates that human and mouse Plexin-B2 is
highly expressed on macrophages, cDCs, and pDCs, with much
less to little found on B and T cells (Fig. 1A, B). This expression
pattern was analyzed in the wild type (Plxnb2
+/+)a n dP l e x i n - B 2
deficient (Plxnb2
2/2) reconstituted mice at the protein level by
flow cytometry (Fig. 1C), with the reconstituted wild type serving
as a negative control. Plexin-B2 is highly expressed on B220
+
PDCA-1
+ pDCs and CD11c
+ B220
2 cDCs in spleen and bone
marrow. Plexin-B2 is also expressed moderately on splenic
macrophages and higher on F4/80
+ macrophages. In addition
bone marrow F4/80
+ cells show two populations based on
Plexin-B2 expression. Bone marrow-derived B220
+ B cells
also express a higher amount of Plexin-B2 than splenic B cells.
The low levels of B cell Plexin-B2 transcript detected by in silico
studies (Fig. 1A, B) and the much higher protein expression
(Fig. 1C) might reflect post-transcriptional control of Plexin-B2
in B cells. Very little Plexin-B2 was detected on TCR
+CD4
+
Tc e l l s ,T C R
+CD8
+ T cells, NK1.1
+ n a t u r a lk i l l e r( N K )c e l l s ,
or NK1.1
+TCR
+ NK T cells, consistent with the in silico
studies.
Reconstitution of the immune system with Plxnb2
2/2
cells is equivalent to wild type
Mice lacking Plexin-B2 (Plxnb2
2/2) have been previously shown
to have a severe phenotype, exhibiting defects in neural tube
closure, cerebellar disorganization and misregulated granule cell
proliferation [31,38]. To study the immune system, it was
necessary to perform fetal liver transplant from Plxnb2
2/2 donor
backcrossed onto a C57BL/6 background for at least ten
generations into C57BL/6 CD45.1
+ recipients (Fig. 2). We and
others have shown that plexins can affect cell proliferation and
homeostasis [36,39–43]. Therefore we studied the ability of
Plxnb2
2/2 cells to reconstitute the mouse immune system. In the
spleen and bone marrow the total number and the reconstituted
percentage of B220
+ CD11c
2 (cDC), CD11c
low PDCA-1
+ (pDC)
and F4/80
+ (macrophage) cells, which express high levels of
Plexin-B2, are equivalent in recipients of wild type and Plxnb2
2/2
fetal livers (Fig. 3A). This also holds true for B220
+ CD11c
2 (B),
TCR
+ CD4
+, and TCR
+ CD8
+ T cell percentages in the spleen
and bone marrow (Fig. 3A). Furthermore, the total percentage of
reconstituting donor (CD45.2
+) cells compared to recipient
(CD45.1
+) is comparable for recipients of either Plxnb2
2/2 or
wild type cells (Fig. 3B). These data suggest that Plexin-B2 does not
affect cell proliferation or reconstitution of the mouse immune
system in the fetal liver engraftment system. Additionally, in vitro
generated macrophages derived from Plxnb2
+/+ and Plxnb2
2/2
reconstituted bone marrow equally express the macrophage
marker F4/80 (Supplemental Fig. S1) and produce similar cell
numbers, supporting our in vivo mouse data which suggests that
Plexin-B2 does not have an effect on hematopoietic cellular
reconstitution.
Plexin-B2 does not affect cytokine response in
macrophages
Toll-like receptors (TLRs) function as pathogen sensors on cells
by recognizing pathogen-derived products, and ligation of TLRs
by their agonist can initiate an inflammatory response [44].
Plexins and their semaphorin receptors have been shown to
modulate cytokine secretion in response to TLRs, as described in
the examples below. Plexin-A1 is required for upregulation of
IFNa after TLR stimulation [45]. Plexin-A4 is required for
inflammatory cytokine production in response to variety of TLR
agonist [46]. Blocking antibodies to Plexin-B1 have been shown to
abrogate Sema4D-induced cytokine modulation [22]. To deter-
mine if Plexin-B2 also contributes to cytokine response after TLR
signaling, the inflammatory cytokines TNF and IL-6 in cell
supernatants of macrophages stimulated by the TLR ligands
Poly(I:C) (polyinosinic-polycytidylic acid, TLR3 agonist), LPS
(lipopolysaccharide, TLR4 agonist), and R837 (imidazoquinoline
compound imiquimod, TLR7 agonist) were assessed (Fig. 4A, B)
[44]. In response to TLR ligands, Plxnb2
2/2 and wild type
macrophages secreted comparable levels of TNF and IL-6,
indicating that Plexin-B2 does not play a role in the production
or release of cytokines measured in this study.
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PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24795Figure 1. Plexin-B2 is expressed in the human and mouse immune system. cDNA expression level of Plxnb2 in A) mouse and B) human
immune cells from BioGPS database [37]. C) Plexin-B2 protein expression by flow cytometry of ex-vivo mouse spleen and bone marrow cells. pDCs
were gated on B220
+ PDCA-1
+ cells. cDCs were gated on CD11c
+ B220
2 cells. Macrophages were gated on F4/80
+ CD11c
2 cells. B cells were gated on
B220
+ cells. T cells were gated on TCR
+ cells. NK cells were gated on NK1.1
+ TCR
2 cells, and NK T cells on NK1.1
+TCR
+ cells. Wild type fetal liver
reconstituted mice stain positive with anti-Plexin-B2 antibody in cells that express Plexin-B2 and are indicated by unfilled histograms. Plxnb2
2/2
reconstituted mice do not stain positive for Plexin-B2 and are indicated by filled histograms. Results are representative of at least four experiments,
n=8 per group.
doi:10.1371/journal.pone.0024795.g001
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macrophages
Plexin-B2 has been shown in the nervous system to mediate cell
guidance, migration, and proliferation. These data prompted us to
examine if Plexin-B2 could contribute to cell movement in
macrophages. We compared the motility of Plxnb2
2/2 and wild
type macrophages on glass bottom dishes using time-lapse
microscopy. Three independent movies of Plxnb2
2/2 and wild
type cells show that the mean velocity of Plxnb2
2/2 macrophages
is significantly higher than wild type (Fig. 5A, B and Videos S1, S2,
S3, S4). Cell morphology and size were similar between Plxnb2
2/2
and wild type macrophages throughout the experiments. We also
stimulated macrophages with M-CSF and found that while wild
type macrophage motility increased with M-CSF stimulation,
Plxnb2
2/2 macrophage motility was unchanged when sham and
M-CSF-treated samples were compared. Together these data
indicate that Plexin-B2 serves as a motility brake in macrophages
during steady state.
We also explored the directional migration capacity of Plxnb2
2/2
macrophages in transwell assays (Fig. 5C). Macrophages have been
demonstrated to migrate towards the attractive cytokines M-CSF
and CXCL12, and fetal bovine serum (FBS), [47–49]. The data
show that migration of Plxnb2
2/2 macrophages towards M-CSF,
CXCL12, and serum is normal compared to wild type. In all cases,
Plxnb2
2/2 cells actually trend towards reduced migration but the
results were not statistically significant. This suggests that while
Plexin-B2 negatively regulates cell motility in steady state
macrophages, directed migration towards M-CSF, CXCL12, and
FBS are not impeded by the absence of Plexin-B2.
Plexin-B2 Regulates Rac and Cdc42
Previous studies with overexpressed Plexin-B2 in Swiss 3T3 cells
have shown that Plexin-B2 binds to the active, GTP-bound form
of Rac and contains a Rac binding motif in its intracellular tail
[24]. Following the findings that Plexin-B2 affects cell motility, we
investigated if this regulation of motility could be related to Plexin-
B2 dependent regulation of Rac Rac and Cdc42 have been
demonstrated to modulate cell migration and motility [28,50,51].
The GTP binding state of Rac and Cdc42 was assessed using
GST–PBD (glutathione S-transferase PAK1 p21-binding domain)
beads to pull down active Rac and Cdc42 from cell lysate followed
by specific detection of each of the molecules by western blot
[52,53]. In the steady state, sham treated Plxnb2
2/2 macrophages
repeatedly had more GTP bound Rac and Cdc42 than wild type
(Fig. 6A). Following stimulation with M-CSF for two minutes, the
difference was reciprocated in that wild type cells showed an
increase in active Rac and Cdc42 while Plxnb2
2/2 cells showed a
decrease in active Rac and Cdc42 (Fig. 6A). At the ten minute
timepoint both wild type and Plxnb2
2/2 macrophages showed
increased levels of active Rac and Cdc42, although the level in the
WT was moderately higher (Fig. 6A). This suggests that Plexin-B2
is a negative regulator of Rac and Cdc42 when macrophages were
sham treated and were in steady state, but was actually required
for proper levels of Rac-GTP and Cdc42-GTP levels at the
2 minute time point after stimulation with M-CSF. The latter is in
agreement with the trend of lowered migration of Plxnb2
2/2
macrophages in response to M-CSF, CXCL12, and FBS shown in
Fig. 5. Studies with the closely related protein Plexin-B1 have
shown that Plexin-B1 binding to Rac-GTP occurs in steady state
without additional stimulation needed [24]. Our data shows that
Plexin-B2 is similar to Plexin-B1 in that it affects steady-state Rac-
GTP but additionally found that Plexin-B2 also regulates Cdc42-
GTP levels. We examined the effect Plexin-B2 on the ERK
(extracellular-signal-related-kinase) pathway, as previous studies of
Plexin-B1 have shown that ERK is phosphorylated downstream of
Plexin-B1 (Fig. 6B) [54]. Phosphorylated ERK levels in Plxnb2
2/2
and wild type macrophages were equivalent in response to sham
treatment and in response to treatment with M-CSF at the two
Figure 2. Schematic of Fetal Liver Transplant. A Plxnb2
+/2 male is crossed to a Plxnb2
+/2 female. Fetal liver cells are harvested from Plxnb2
+/+ or
Plxnb2
2/2 littermate fetal livers at day 14 of gestation. 2610
6 fetal liver cells are injected i.v. into congenic, lethally irradiated CD45.1 recipient mice.
Mice are utilized 6–8 weeks post-transplant.
doi:10.1371/journal.pone.0024795.g002
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PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e24795Figure 3. Immune system reconstitution with Plxnb2
2/2 fetal livers is similar to wild type. A) Flow cytometry of reconstitution of congenic
CD45.1
+ mice with wild type and Plxnb2
2/2 fetal livers (CD45.2
+) in the splenic and bone marrow compartments six weeks post-transplant. cDCs are
designated as B2202/CD11c+ cells, pDCs as CD11c
+ B220
+, and B cells as B220
+ CD11c
2. pDCs were further defined as CD11c
low and PDCA-1
+.
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PLoS ONE | www.plosone.org 5 September 2011 | Volume 6 | Issue 9 | e24795and ten minutes timepoints following treatment. These data
represent the first evidence that the effect of Plexin-B2 in steady
state cells not exposed to additional cytokine stimulation is to serve
as a brake for Rac and Cdc42 activation.
Plexin-B2 does not affect macrophage phagocytosis
The Rho family of GTPases regulate the process of phagocy-
tosis, in which actin dynamics facilitate the cellular processes of
membrane extension, phagocytic cup formation and closure, and
particle uptake [reviewed in 55]. Rac and Cdc42 mediate FccR
mediated phagocytosis in macrophages [56–59]. Plexin-C1, in
response to ligation by the viral semaphorin A39R, downregulates
phagocytosis [60].
To test whether the negative regulation of Rac and Cdc42 by
Plexin-B2 in macrophages has an effect on phagocytosis, we
performed experiments to examine the uptake of GFP-E. coli,
latex beads, and antibody coated thymocytes (Fig. 7A, B, C).
Plxnb2
2/2 or wild type macrophages were plated in complete
DMEM and given either GFP-E. coli, fluorescent latex beads, or
antibody coated thymocytes and assayed for cellular uptake using
flow cytometry at different time points. Both Plxnb2
2/2 and wild
type macrophages were capable of phagocytosing all treatment
groups. However, the ability to phagocytose antibody coated
thymocytes repeatedly trended towards greater uptake of these
thymocytes by Plxnb2
2/2 macrophages, although this difference is
not significant.
Plexin-B2 negatively regulates wound healing
To extend the studies of the role of Plexin-B2 in functions of
macrophages, we explored the possibility that Plxnb2
2/2 macro-
phages may be different from wild type in their level of F-actin,
ability to bind to extracellular matrix proteins, or their ability to
participate in wound-healing. To explore the effects of Plexin-B2
on the level of F-actin present in macrophages , we stained
Plxnb2
2/2 and wild type macrophages with fluorescently labeled
phalloidin, which binds to F-actin. Cells were sham (DMEM)
treated or treated with 50 ng/ml of M-CSF for 2 and 10 minutes
in DMEM (Fig. 8A). Macrophages of both genotypes in the sham
treatment groups had similar cell morphology and actin
distribution. In response to 2 minutes of treatment with M-CSF,
cells from both genotypes were capable of ruffling and demon-
strated similar ruffling behavior. At the 10 minute timepoint after
treatment with M-CSF, both wild type and Plxnb2
2/2 macro-
phages took on the classic egg shape of the macrophage, and had
similar patterns of actin staining.
To explore the role of Plexin-B2 in adhesion and migration
towards extracellular matrix protein, macrophages were harvested
and seeded in plain DMEM in the upper well of a 24 well
fibronectin-coated transwell plate containing either DMEM, M-
CSF and DMEM, or FBS (10%) and DMEM (Fig. 8B). Cells were
allowed to migrate for 20 hours, and were quantified by optical
density of stained cells. Both wild type and Plxnb2
2/2 macro-
phages migrated into the extracellular matrix coated transwells.
We also determined the ability of Plxnb2
2/2 macrophages to
adhere to fibronectin coated plates (Fig. 8C). Cells were plated
onto fibronectin-coated 96 well plates for 20 minutes, washed, and
the adherent cells were quantified by bioluminescence. Plxnb2
2/2
macrophages adhered to the extracellular matrix protein fibro-
nectin in similar proportions to wild type macrophages.
Wound healing assays serve as a model of in vitro cell movements
required to facilitate wound closure [61]. To explore the ability of
Plxnb2
2/2 macrophages to participate in in vitro would healing
assays (Fig. 8D and Videos S5 and S6), cells were seeded in 12 well
plates in complete DMEM and rested overnight. An artificial
wound in the cell monolayer was created using a pipette tip, and
cells were monitored by live cell imaging. Cells were scored for
wound closure over time in the image in pixels per second, and
then converted to micrometers per second. Plxnb2
2/2 macro-
phages were able to move into the wound area at a rate of
5.44 pixels per second, while wild type macrophages moved into
the wound area at only 3.43 pixels per second. The Plxnb2
2/2
macrophages closed the in vitro wound significantly faster
Figure 4. Plexin-B2 does not affect cytokine secretion. Wild type and Plxnb2
2/2 macrophages were plated in complete DMEM and treated for
16 hours with TLR ligands Poly(I:C) (10 ug/ml) (TLR 3 agonist), LPS (1 ug/ml) (TLR 4 agonist), and R837 (4 ug/ml) (TLR 7 agonist). Poly(I:C), LPS, and
R837 were purchased from InvivoGen. Supernatants were collected at the 16 hour time point and assessed for secretion of A) TNF and B) IL-6 by
ELISA. Graphs are representative of three independent experiments, n=3 mice per group.
doi:10.1371/journal.pone.0024795.g004
Macrophages were defined as F4/80
+ cells. T cells were first gated on TCR
+ cells, and then divided into subpopulations by the CD4
+ and CD8
+
markers. NK cells were defined as NK1.1+/CD42 and NKT cells as NK1.1+CD4+. B) Total donor reconstitution in the spleen and bone marrow were
similar between wild type and Plxnb2
2/2 mice. CD45.2 marked the donor, Ly5.1
+ cells. CD45.1 marked the residual host, Ly5.2
+ cells. Figures are
representative plots of four separate experiments. n=5 mice per group.
doi:10.1371/journal.pone.0024795.g003
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PLoS ONE | www.plosone.org 6 September 2011 | Volume 6 | Issue 9 | e24795(p=0.038) than wild type macrophages, suggesting that Plexin-B2
might participate in wound healing.
Discussion
This is the first report to explore the expression of Plexin-B2
on macrophages, cDCs, and pDCs. We found that Plexin-B2 is
not expressed on resting B cells in the spleen, in agreement with
previously reported expression of Plexin-B2 in B cells within T-
dependent germinal centers [33]. Plexin-B2 is also not highly
expressed in CD4
+ or CD8
+ splenic T cells, NK or NK T cells at
the transcript and protein level. In the BioGPS cDNA database
[37], Plexin-B2 is most highly expressed in the macrophage,
cDC and pDC in the immune system. Our protein data confirms
the database results. Interestingly, the same database shows
Plexin-B1 has no immune system cDNA expression above
median, and Plexin-B3 is most highly expressed in mast cells
(data not shown). Other studies have demonstrated that Plexin-
B1 is expressed in B cells, monocytes, and dendritic cells in
humans [22,23]. This suggests that expression level of different B
family plexins is cell type specific and may be regulated by
activation state of the cell.
Figure 5. Plxnb2
2/2 cells have higher motility than wild type macrophages. A) Cells were plated in complete DMEM, rested overnight, and
treated with sham (warmed DMEM) or warmed DMEM and 50 ug/ml M-CSF. Representative cell movement tracks over a 2.5 hour time period on
sham or M-CSF treated wild type or Plxnb2
2/2 macrophages. B) Combined velocity scores of wild type and Plxnb2
2/2 bone marrow macrophages in
sham or treated (50 ng/ml M-CSF) groups in 5A. Cell velocity was scored in 45 cells per group per experiment. The experiment was repeated three
separate times using cells from different mice in each experiment. C) Macrophage transwell migration towards CSF, CXCL12, or FCS. Cells were placed
in the upper chamber in plain DMEM and chemokines in plain DMEM in the lower chamber of migration plates. Cells were allowed to migrate for four
hours towards different concentrations of cytokines (M-CSF, 0–500 ng/ml or CXCL12, 0–1000 ng/ml) or overnight towards serum (0–20%). Cells were
quantified and normalized to a standard curve of each cell type. Graphs are representative of at least three independent experiments. n=4 mice per
group.
doi:10.1371/journal.pone.0024795.g005
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PLoS ONE | www.plosone.org 7 September 2011 | Volume 6 | Issue 9 | e24795The functional analyses showed a large number of functions
that are unaffected by Plexin-B2, however the positive findings are
that Plxnb2
2/2 macrophages have higher steady state motility than
wild type macrophages by live cell microscopy, and perform in vitro
wound healing at a faster rate than wild type macrophages,
suggesting that Plexin-B2 is a negative regulator of cell motility
under these conditions. The data demonstrates that directional
migration of both Plxnb2
2/2 macrophages in response to cytokines
M-CSF, CXCL12 or FBS are equivalent or even trended lower
than wild type macrophages, suggesting that stimulated, direc-
tional migration by these stimuli is not statistically affected by
Plexin-B2. The majority of the studies of Plexin B family members
have relied on activation of the plexin receptor by its ligand or by
synthetic dimerization. Here we show that in steady state,
endogenous Plexin-B2 regulates macrophage motility. It is possible
that at the steady state, Plexin-B2 may be dimerized in an
autocrine fashion in our system by one of its reported ligands
Sema4A, Sema4C, or Sema4D [7,38,62,63]. Under this scenario,
the semaphorin ligand could be secreted by macrophages, or could
be provided by neighboring cells in the culture. However, we are
able to use a monoclonal antibody to detect Plexin-B2 surface
expression, indicating that either the anti-Plexin-B2 antibody
binds to an epitope of Plexin-B2 that is not occupied by ligand
binding or that Plexin B2 is not bound to its ligand in our
experimental conditions.
To explore the mechanism of Plexin-B2 negative regulation of
cell motility, GTP pull down assays were carried out to determine
the amount of active Rac and Cdc42. The data show that in the
unstimulated state, Plxnb2
2/2 cells have higher levels of the GTP
bound, active forms of Cdc42 and Rac. Previous reports have
shown that Plexin-B2 in its undimerized form binds to Rac-GTP
in yeast and in bacterial overexpression studies [24]. Our data
suggests that in the absence of Plexin-B2, there is more active Rac.
One possibility is that Plexin-B2 might increase RacGAP (Rac
GTPase accelerating protein) activity by serving as a RacGAP
itself or recruits a RacGAP to the Plexin-B2 complex. However
structural and biochemical studies of Plexin-B1 have shown that
Plexin-B1 does not function as a RacGAP, suggesting that the
Plexin-B1 modulation of Rac is through other mechanisms
[64,65]. The intracellular tails of Plexin-B1 and Plexin-B2 are
similar (61% identical in their amino acid sequence – data not
shown). Whether Plexin-B2 also does not function as a RacGAP
requires further investigation. Studies of Plexin-B3 have demon-
strated that Plexin-B3 regulates Rac activation in a ligand-
dependent manner in glioma cells by binding to RhoGDI, which
prevents Rac activation and reduces cell motility [66]. It is possible
that at the steady state, Plexin-B2 may be interacting in a similar
manner. However, upon stimulation by M-CSF, additional
pathways may contribute to the regulation of Plexin-B2 and
Rac. Studies of prostate cancer samples show that mutations
present in the Rac binding domain of Plexin-B1 result in an
increase in cell motility [67]. In our system, Plexin-B2 facilitates
the downregulation of Rac and Cdc42 without the addition of
ligand, suggesting that Plexin-B2 functions without ligand or that
its ligand is derived autonomously. It is possible that a component
in serum present in the cell culture of the macrophages may also
contribute to the differences in activation state that we observed.
Intriguingly, after cell stimulation by M-CSF for two minutes,
levels of active Rac and Cdc42 are briefly reduced in the Plxnb2
2/2
cells. The biologic relevance of this is unclear.
This study revealed several functions that are not regulated by
Plexin-B2. The reconstitution ratios of wild type or Plxnb2
2/2 fetal
liver cells are similar in wild type recipients, and the percent of
specific immune cell populations in the spleen and bone marrow
reconstituted equivalently. This includes cell types that express the
highest levels of Plexin-B2: the cDC, pDC, and macrophage.
Numbers of macrophage cells derived from bone marrow cultures
of Plxnb2
2/2 and wild type cells are equal, suggesting that Plexin-
B2 does not contribute to detectable differences in immune system
ontogeny or proliferation in this study. Antibody-mediated
phagocytosis is a Rac and Cdc42 dependent mechanism [59].
Therefore we explored the phagocytic capacity of Plxnb2
2/2
macrophages compared to wild type. However, the findings show
that the phagocytosis of GFP-E. coli and latex beads is similar for
Plxnb2
2/2 and wild type macrophages, although, there was a
trend of increased phagocytosis of antibody-coated thymocytes by
Plxnb2
2/2 macrophages. Antibody-mediated phagocytosis has
been shown to be dependant on Rac and Cdc42 [58], while
bacteria bypass the need for activation of the small GTPases for
cellular uptake [68]. It is possible that the over-activation of Rac
and Cdc42 in the absence of Plexin-B2 leads to a modest
upregulation of antibody-mediated phagocytosis, but not phago-
cytosis of E. coli and latex beads. The modest upregulation of
antibody-mediated phagocytosis was consistently observed, but yet
not statistically significant, suggesting that other signaling
pathways important for FcR mediated phagocytosis may com-
pensate for loss of Plexin-B2. Previous reports have shown that
Plexin-B1 and other plexins can influence cytokine production in
monocytic cells, suggesting the Plexin-B2 may function similarly
[22,69]. However this study shows that TNF and IL-6 production
and secretion in response to TLR ligands are similar between wild
type and Plxnb2
2/2 macrophages. Finally, we did not observe
Figure 6. Plexin-B2 inhibits active Rac and Cdc42. WT and
Plxnb2
2/2 macrophages were plated, rested overnight, and treated
with sham (warmed DMEM) or M-CSF (50 ng/ml of M-CSF in warmed
DMEM) and assessed for A) RacGTP, Cdc42GTP, total Rac and total
Cdc42 using a GST-PBD pulldown assay followed by western blot. B)
Western blot of ERK activation as assessed by phospho-ERK level in cells
treated as above. Total protein level was determined by western blot of
GAPDH. Results are representative of four separate experiments. n=4
mice per group.
doi:10.1371/journal.pone.0024795.g006
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2/2 macrophages in their
levels of F-actin, or in their ability to adhere or migrate to
fibronectin, suggesting that Plexin-B2 does not affect F-actin levels
present in macrophages, and also does not affect the ability of
macrophages to adhere or migrate towards extracellular matrix
proteins.
During the submission of this paper, a paper was published
suggesting that Sema4C may be the ligand to Plexin-B2 in the
developing kidney [70], while another paper suggests that Plexin-B2
has two ligands in the nervous system, Sema4C and Sema4G [71].
Previous literature implicated Sema4C and Sema4A as potential
ligands for Plexin-B2 in non-immune cells [7,38,63]. Research in
the field has consistently demonstrated that the issue of Plexin
ligands is complex. Plexins may have multiple semaphorin ligands
that vary by cell type or tissue, may bind to other types of ligands, or
maybindhomophilically[72–74]. InFig. S2,we show that Sema4C
is expressed in macrophages, however its expression pattern is
strongly induced by LPS, while that of Plexin-B2 is reduced by LPS,
suggesting Sema4C may not be the ligand for Plexin-B2 in
macrophages. Future research will determine if Sema4C or other
semaphorins serve as an autocrine or paracrine ligand of Plexin-B2
in the macrophage, and the effects of Plexin-B2 ligands on
macrophage function and cytokine secretion.
In summary, this study shows that Plexin-B2 is highly expressed
in the immune system on cells of monocytic-myeloid lineage,
including the cDC, pDC, and macrophage. Plexin-B2 has been
shown previously to bind to the activated form of Rac, but the
physiological consequence of Plexin-B2 Rac-GTP binding is
unknown. We show that ex-vivo Plxnb2
2/2 macrophages have
higher levels of activated Rac and Cdc42 and increased cell
motility in steady state. In addition, Plexin-B2 exerts a negative
effect on an in vitro wound healing assay. Our data suggest that the
function of Plexin-B2 in steady state is to negatively regulate Rac
and Cdc42 and to maintain a brake on cell motility in steady state
cells. Future research into the role of Plexin-B2 in wound healing is
another area that should be of interest.
Materials and Methods
Ethics Statement
All studies were conducted in accordance with the National
Institutes of Heath Guide for the Care and Use of Laboratory
Animals and were approved by the Institutional Animal Care and
Use Committee (IACUC) guidelines of the University of North
Carolina at Chapel Hill (protocol #08-200).
Mice
C57BL/6 (CD45.2) and congenic C57BL/6 (CD45.1) mice
were purchased from National Cancer Institute (Boston, MA).
Plxnb2
2/2 mice were described previously and were a kind gift
Figure 7. Plexin-B2 does not significantly affect phagocytosis. Wild type and Plxnb2
2/2 bone marrow derived macrophages were incubated
with A) GFP-E. coli, B) latex beads, or C) opsonized thymocytes (1:10 ratio E. coli, bead, or T cells: macrophage) for 30, 60, or 90 minutes. Uptake was
measured by fluorescence and flow cytometry. Graphs are representative or four independent experiments. n=5 mice per group.
doi:10.1371/journal.pone.0024795.g007
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2/2 cells demonstrate faster wound healing than wild type macrophages. A) F-actin distribution in sham and M-CSF
treated macrophages. Wild type and Plxnb2
2/2 macrophages were plated on glass coverslips, rested overnight, and fixed following sham (plain
DMEM) treatment or treatment with 50 ng/ml M-CSF in DMEM for 2 or 10 minutes. Cells were imaged on an Olympus IX-70 (Center Valley, PA).
Pictures are representatives of two different experiments with 10 pictures per treatment group, with cells from four mice per group. B) Migration of
macrophages into extracellular matrix protein. Wild type and Plxnb2
2/2 macrophages were seeded into the top chamber of a fibronectin coated
transwell apparatus in plain DMEM. Cells were allowed to migrate towards plain DMEM, DMEM with 100 ng/ml M-CSF, and DMEM with 10% FBS for
20 hours and quantified by optical density. Graph is representative of two separate experiments performed with cells from four mice per group. C)
Adhesion to extracellular matrix protein. Wild type and Plxnb2
2/2 macrophages were plated on fibronectin (20 ug/ml) coated plates and allowed to
adhere for 20 minutes. Plates were washed and adherent cells were quantified by ToxiLight Bioassay Kit (Lonza, Rockland, ME). Graph is
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+/2 mice were back-
crossed with C57BL/6 mice at least 10 generations at the University
of North Carolina Chapel Hill. Mice were used at six to eight weeks
of age and were housed in a pathogen-free barrier facility at the
University of North Carolina Chapel Hill. Plxnb2
+/2 mice were
crossedto obtainPlxnb2
2/2 and wild type fetal livers from stage E14
pups. Fetal liver cells were then injected intravenously into lethally
irradiated C57BL/6 CD45.1to reconstitute the immune system and
analyzed 6–10 weeks post reconstitution [75].
Cell culture
Macrophages were generated by bone marrow culture in L929
media. In brief, mouse femurs and tibias were removed from 6–8
week old mice, cleaned, and aspirated to remove bone marrow.
Cells were cultured in L929 for six days. Macrophages were
harvested and replated in complete DMEM media [DMEM, 10%
heat inactivated FBS, non-essential amino acids, L-glutamine,
sodium pyruvate, and penicillin/streptomycin (P/S)], and rested
overnight before experiments.
Reagents
Poly(I:C), Ultrapure LPS, and Imiquimod (R837) were from
InvivoGen. M-CSF was from R&D Systems (Minneapolis, MN).
Antibodies for western blotting included Rac1 (C-14; sc-217),
Cdc42 (B-8; sc-8401), phospho-ERK1/2 (Thr202/Thr204)
(197G2; 4377) from Santa Cruz Biotechnology (Santa Cruz, CA)
and GAPDH (MAB374) from Millipore (Billerica, MA). Second-
ary goat a mouse-HRP (horse radish peroxidase) and goat a
rabbit-HRP antibodies are from Santa Cruz Biotechnology (Santa
Cruz, CA). Beads for assays of GTP-bound Rac1 and Cdc42
glutathione-sepharose (GST) bead conjugated with Pak1 binding
domain (Rac1 and Cdc42) were kindly provided by Dr. Keith
Burridge (University of North Carolina, Chapel Hill).
Flow cytometry
Antibodies used for flow cytometry included: B220 (RA3-6B2),
CD45.2 (104), CD45.1 (A20), CD4 (L3T4), F4/80 (BM8), CD8
(Ly-2), TCR (H57-597), CD11b (M1/70), CD11c (N418), NK1.1
(NKR-P1C) PDCA-1 (BST2, CD317) and Plexin-B2 (3E7) from
eBioscience (San Diego, CA). Single cell suspensions of spleen and
bone marrow were lysed in ACT to remove red blood cells,
washed and resuspended in FACS buffer (16PBS and 2% FBS) at
1610
6 cells per well and stained with antibody combinations. All
experiments were performed on a FACSCalibur (BD Biosciences,
Franklin Lakes, NJ) or Cyan (Dako, Carpinteria, CA) and
analyzed with FlowJo software (Tree Star, Ashland, OR).
Live Cell Microscopy
1610
4 cells were plated on glass bottom dishes (MatTek
Ashland, MA P35G-1.5-10-C). Cells were imaged on a Nikon
Biostation (Belmont, CA) with a 206objective. Cell velocity was
analyzed using manual tracking in ImageJ [76]. Images were
collected every 5 minutes for a total time of 2.5 hours for
unstimulated cells or following treatment with 50 ng/ml M-CSF.
For each treatment three separate movies were filmed and 45 cells
scored for velocity. n=3 mice per group.
Migration
Macrophages were M-CSF starved in complete DMEM
overnight, harvested, and seeded in plain DMEM at 2610
5 per
upper well of 96-well transwell plates with 8 mm pores (ChemoTx
System; NeuroProbe, Gaithersburg, MD), over chemokines (Pe-
protech, Rocky Hill, NJ) in serum-free DMEM or FBS (Gibco,
Carlsbad, California) inDMEM, and incubatedat 37uC for 4 hours
for migration towards chemokine or overnight for migration
towards serum. Migrated cells were quantified using ToxiLight
Bioassay Kit (Lonza, Rockland, ME). Experiments were repeated at
least three times. n=4 mice per group. Experiments with cells
migrating towards fibronectin were performed following the
manufacturers’ instructions (Millipore, Billerica, MA). In brief,
macrophages were harvested and seeded in plain DMEM at 2610
5
per upper well of a 24 well fibronectin coated transwell plates
containing either DMEM, M-CSF (100 ng/ml) and DMEM, or
FBS(10%)and DMEM.Cellswere allowedtomigratefor20 hours,
and were quantified by optical density of stained cells. Experiments
were repeated two times, n=4 mice per group.
Detection of GTP-bound Rac1, Cdc42, and pERK
Cells were plated at 2610
6 cells per well in six well plates and
treated with 50 ng/ml M-CSF or media for the indicated times.
Assays for GTP-bound Rac1 and Cdc42 were performed as
described [77]. Cells were lysed and precipitated using GST-PBD
beads for Rac and Cdc42. Bead bound proteins and cell lysate
were resolved on a NuPAGE (Invitrogen Carlsbad, CA) gel and
were transferred onto nitrocellulose membranes. Membranes were
blocked with 10% milk and probed with primary antibodies
against Rac1 and Cdc42 followed by appropriate secondary HRP
conjugated antibody for detection. For detection of pERK cells
were plated as above, treated with 50 ng/ml M-CSF for the
indicated times, lysed and resolved on a NuPage (Invitrogen
Carlsbad, CA) gel.
Phagocytosis
Macrophages were plated at 1610
5 cells per well in a 96 well
non-tissue culture treated plate in 100 ul of macrophage media
without antibiotics. Cells were rested overnight and then treated
with 1610
7 GFP E. coli (green fluorescent protein expressing
Eshericia coli kindly provided by Dr. Glenn Matoshima, University
of North Carolina Chapel Hill), 1610
7 fluorescent latex beads
(Invitrogen F13080, Carlsbad, CA), or 1610
6 CFSE (carboxy-
fluorescein diacetate succinimidyl ester, Invitrogen, Carlsbad, CA)
labeled, antibody labeled (CD45.2, mouse IgG2a) thymocytes as
previously described [78]. Cells were washed with media,
extracellular fluorescence quenched with 0.2% Trypan Blue
(Sigma T8154, St. Louis, MO), fixed in 0.1% EM-grade
formaldehyde and analyzed by flow cytometry for percent of
fluorescent positive cells.
ELISA
Macrophages were plated at 2610
5 cells per well in a 96 well
plate and stimulated overnight. Cell supernatants were quantified
using the ELISA kits for mouse TNF-a (555268) or IL-6 (555240)
(BD Biosciences San Jose, CA).
representative of two separate experiments with cells from four mice per group. D) Wound healing assay. Wild type and Plxnb2
2/2 macrophages
(1610
6) were plated on 12 well plates. An artificial wound was introduced using a 200 ul pipette tip, and cells were imaged closing the wound every
10 minutes at four points per scratch for 24–48 hours using an Olympus-IX-70 inverted microscope with live cell imaging capability. The rate of
change of the area of the scratch was measured over time using the NIH ImageJ program. The calculated area is in terms of pixels, and the rate of
movement is calculated as pixels/sec and converted to micrometers/sec. Experiments were repeated two times with 6 wells per group, using cells
from four different mice per group.
doi:10.1371/journal.pone.0024795.g008
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Cells were seeded at 1610
4 cells in complete DMEM on glass
coverslips and rested overnight. Cells were then sham treated with
warmed plain DMEM, or treated with 50 ng/ml M-CSF in
warmed DMEM for 2 or 10 minutes. Cells were fixed with 300 ul
ice cold 4% paraformaldehyde in Krebs media for 10 minutes,
washed in PBS, and permeabalized in 0.1% Triton X in PBS for
5 minutes at room temperature. Cells were blocked in 5% BSA,
stained with fluorescently labeled phalloidin (Invitrogen, Carlsbad,
California) and mounted. Cells were imaged at 406 using an
Olympus BX-61 (Center Valley, PA).
Adhesion to extracellular matrix protein
Well of a ninety six well plate were coated with fibronectin
(20 ug/ml) overnight and washed with PBS. Cells were harvested,
resuspended in media at 5610
5 cells/ml and incubated at 37uC
without a top. Cells (50 ul) were then plated onto the fibronectin
coated plate and incubated at 37uC without a lid for 20 minutes,
washed 2 times with PBS. Adherent cells lysed and quantified to a
standard curve using the ToxiLight Bioassay Kit (Lonza, Rock-
land, ME).
Wound healing assay
Wound healing assays were performed as previously described
[61]. Macrophages were seeded (1610
6) on 12 well plates (glass or
plastic) in complete DMEM and rested overnight. An artificial
wound was introduced using a 200 ml pipette tip. Cells were
imaged using an Olympus IX-70 inverted microscope with live cell
imaging capability every 10 minutes at four points per scratch for
24–48 hours. To calculate the rate of migration, the movies were
converted to TIFF stacks and the rate of change of the area of the
scratch was measured over time using NIH ImageJ program. The
area calculated by ImageJ is in terms of pixels, and the rate of
movement is calculated as pixels/sec and converted to microme-
ters/sec. Experiments were repeated two times with 6 wells per
group, using cells from two different mice per group in each
experiment.
Statistical analysis
Statistical significance was determined with two-tailed Student’s
t test. All p values less than 0.05 were considered significant.
Supporting Information
Figure S1 Macrophage marker F4/80 is expressed by
bone marrow derived wild type and Plxnb2
2/2 macro-
phages. Flow cytometry plot of A) Plxnb2
2/2 and B) wild type
bone marrow derived macrophages. Bone marrow cells were
plated on plastic plates and grown in complete DMEM and L929
media. Cells were harvested, blocked, and stained with antibody
against F4/80 and Plexin-B2 (ebiosciences, San Diego, CA). A
flow cytometry plot of mixed wild type and Plxnb2
2/2 macro-
phages stained with isotype controls for F4/80 and PlexinB2
antibodies are displayed in figure C.
(EPS)
Figure S2 Semaphorin 4C is expressed in the human
and mouse immune system. cDNA expression level of in A)
mouse and B) human immune cells from BioGPS database [37].
(EPS)
Video S1 Live cell video of cell motility of wild type
macrophages. Representative cell movement videos over a
2.5 hour time period. 1610
4 cells were plated on glass bottom
dishes (MatTek Ashland, MA P35G-1.5-10-C) in complete
DMEM, rested overnight, and treated with sham (warmed
DMEM). Cells were imaged on a Nikon Biostation (Belmont,
CA) with a 206 objective at ten different points. Images were
collected every 5 minutes for a total time of 2.5 hours following
sham treatment. Three separate movies were filmed and 45 cells
scored for velocity. Cell velocity was analyzed using manual
tracking in ImageJ [76]. The experiment was repeated three
separate times using cells from different mice in each experiment.
(AVI)
Video S2 Live cell video of cell motility of wild type, M-
CSF treated macrophages. Representative cell movement
videos over a 2.5 hour time period. 1610
4 cells were plated on
glass bottom dishes (MatTek Ashland, MA P35G-1.5-10-C) in
complete DMEM, rested overnight, and treated with 50 ng/ml
M-CSF in warmed DMEM. Cells were imaged on a Nikon
Biostation (Belmont, CA) with a 206 objective at ten different
points. Images were collected every 5 minutes for a total time of
2.5 hours following sham treatment. Three separate movies were
filmed and 45 cells scored for velocity. Cell velocity was analyzed
using manual tracking in ImageJ [76]. The experiment was
repeated three separate times using cells from different mice in
each experiment.
(AVI)
Video S3 Live cell video of cell motility of Plxnb2
2/2
macrophages. Representative cell movement video over a
2.5 hour time period. 1610
4 cells were plated on glass bottom
dishes (MatTek Ashland, MA P35G-1.5-10-C) in complete
DMEM, rested overnight, and treated with sham (warmed
DMEM). Cells were imaged on a Nikon Biostation (Belmont,
CA) with a 206 objective at ten different points. Images were
collected every 5 minutes for a total time of 2.5 hours following
sham treatment. Three separate movies were filmed and 45 cells
scored for velocity. Cell velocity was analyzed using manual
tracking in ImageJ [76]. The experiment was repeated three
separate times using cells from different mice in each experiment.
(AVI)
Video S4 Live cell video of cell motility of Plxnb2
2/2,M -
CSF treated macrophages. Representative cell movement
videos over a 2.5 hour time period. 1610
4 cells were plated on
glass bottom dishes (MatTek Ashland, MA P35G-1.5-10-C) in
complete DMEM, rested overnight, and treated with 50 ng/ml
M-CSF in warmed DMEM. Cells were imaged on a Nikon
Biostation (Belmont, CA) with a 206 objective at ten different
points. Images were collected every 5 minutes for a total time of
2.5 hours following sham treatment. Three separate movies were
filmed and 45 cells scored for velocity. Cell velocity was analyzed
using manual tracking in ImageJ [76]. The experiment was
repeated three separate times using cells from different mice in
each experiment.
(AVI)
Video S5 Live cell videos of in vitro wound closure of
wild type macrophages. Representative live cell imaging of
wound healing assay with wild type macrophages. 1610
6 cells
were plated on 12 well glass or plastic plates in complete DMEM
and rested overnight. An artificial wound was introduced using a
200 ul pipette tip, and cells were imaged closing the wound every
10 minutes at four points per scratch for 24–48 hours using an
Olympus-IX-70 inverted microscope with live cell imaging
capability. To calculate the rate of migration, the movies were
converted to TIFF stacks and the rate of change of the area of the
scratch was measured over time using NIH ImageJ program. The
area calculated by ImageJ [76] is in terms of pixels, and the rate of
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ters/sec. Experiments were repeated two times with 6 wells per
group, using cells from two different mice per group in each
experiment.
(MOV)
Video S6 Live cell videos of in vitro wound closure of
Plxnb2
2/2 macrophages. Representative live cell imaging of
wound healingassaywithPlxnb2
2/2 macrophages.1610
6 cells were
plated on 12 well glass or plastic plates in complete DMEM and
rested overnight. An artificial wound was introduced using a 200 ul
pipette tip, and cells were imaged closing the wound every
10 minutes at four points per scratch for 24–48 hours using an
Olympus-IX-70 inverted microscope with live cell imaging
capability. To calculate the rate of migration, the movies were
converted to TIFF stacks and the rate of change of the area of the
scratch was measured over time using NIH ImageJ program. The
area calculated by ImageJ [76] is in terms of pixels, and the rate of
movementiscalculatedas pixels/secand converted tomicrometers/
sec. Experiments were repeated two times with 6 wells per group,
using cells from two different mice per group in each experiment.
(MOV)
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